Drug Utilization Review Board
Meeting Agenda
Thursday, April 9, 2026 7:15 a.m. to 8:30 a.m.
Google Meet joining info
Video call link: meet.google.com/qbv-rjpz-fst
Or dial: (US) +1 314-474-3014 PIN: 334 496 072#
Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov at least one week prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
1) Call to order - Sharon Weinstein, MD
a) Welcome and Introductions
b) Review and Approval of Minutes
c) Housekeeping - Ngan Huynh, PharmD
2) Prior Authorization Updates - Ngan Huynh, PharmD
3) Review Topic
a) Economic Value of GLP-1 Receptor Agonists Approved for the Treatment of Obesity - Monet Luloh, PharmD
i) Committee Discussion/Questions
4) Public Comment
5) Review New Prior Authorization Criteria
a) Kisunla (donanemab-azbt) - Iris Wan, PharmD
i) Committee Discussion/Questions
ii) Committee Action
b) Agamree (vamorolone) - Ngan Huynh, PharmD
i) Committee Discussion/Questions ii) Committee Action
c) IBAT Inhibitors (Bylvay, Livmarli) - Kyu Yun Park, PharmD
i) Committee Discussion/Questions
ii) Committee Action
d) iDose TR (travoprost intracameral implant) - Ngan Huynh, PharmD
i) Committee Discussion/Questions
ii) Committee Action
6) Next Meeting
a) Date: May 14, 2026
b) Topic: New prior authorization form reviews: Imaavy, Pivya, and Itvisma
7) Adjourned - Sharon Weinstein, MD
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/qbv-rjpz-fst
Or dial: (US) +1 314-474-3014 PIN: 334 496 072#